Pharma & Healthcare
Global Peptide Antibiotics Market Research Report 2025
- Mar 11, 25
- ID: 8518
- Pages: 93
- Figures: 96
- Views: 6
The global market for Peptide Antibiotics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Peptide Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peptide Antibiotics include Pfizer, Novartis, GlaxoSmithKline, Eli Lilly, Theravance, Vicuron Pharmaceuticals, Savara Pharmaceuticals, AMP Therapeutics, Hospira, Kasten, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Antibiotics.
The Peptide Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation
Segment by Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
Segment by Application
Pharma & Healthcare
Food Industry
Commodities
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peptide Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
North American market for Peptide Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peptide Antibiotics include Pfizer, Novartis, GlaxoSmithKline, Eli Lilly, Theravance, Vicuron Pharmaceuticals, Savara Pharmaceuticals, AMP Therapeutics, Hospira, Kasten, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Antibiotics.
The Peptide Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation
Segment by Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
Segment by Application
Pharma & Healthcare
Food Industry
Commodities
Other
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peptide Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Peptide Antibiotics Market Overview
1.1 Product Definition
1.2 Peptide Antibiotics by Type
1.2.1 Global Peptide Antibiotics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ribosomal Synthesized Peptide Antibiotics
1.2.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Peptide Antibiotics by Application
1.3.1 Global Peptide Antibiotics Market Value by Application (2024 VS 2031)
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 Global Peptide Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Peptide Antibiotics Revenue 2020-2031
1.4.2 Global Peptide Antibiotics Sales 2020-2031
1.4.3 Global Peptide Antibiotics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peptide Antibiotics Market Competition by Manufacturers
2.1 Global Peptide Antibiotics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Antibiotics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peptide Antibiotics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peptide Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Antibiotics, Product Type & Application
2.7 Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
2.8 Global Peptide Antibiotics Market Competitive Situation and Trends
2.8.1 Global Peptide Antibiotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide Antibiotics Players Market Share by Revenue
2.8.3 Global Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide Antibiotics Market Scenario by Region
3.1 Global Peptide Antibiotics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peptide Antibiotics Sales by Region: 2020-2031
3.2.1 Global Peptide Antibiotics Sales by Region: 2020-2025
3.2.2 Global Peptide Antibiotics Sales by Region: 2026-2031
3.3 Global Peptide Antibiotics Revenue by Region: 2020-2031
3.3.1 Global Peptide Antibiotics Revenue by Region: 2020-2025
3.3.2 Global Peptide Antibiotics Revenue by Region: 2026-2031
3.4 North America Peptide Antibiotics Market Facts & Figures by Country
3.4.1 North America Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peptide Antibiotics Sales by Country (2020-2031)
3.4.3 North America Peptide Antibiotics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peptide Antibiotics Market Facts & Figures by Country
3.5.1 Europe Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peptide Antibiotics Sales by Country (2020-2031)
3.5.3 Europe Peptide Antibiotics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peptide Antibiotics Sales by Region (2020-2031)
3.6.3 Asia Pacific Peptide Antibiotics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peptide Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peptide Antibiotics Sales by Country (2020-2031)
3.7.3 Latin America Peptide Antibiotics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peptide Antibiotics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peptide Antibiotics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peptide Antibiotics Sales by Type (2020-2031)
4.1.1 Global Peptide Antibiotics Sales by Type (2020-2025)
4.1.2 Global Peptide Antibiotics Sales by Type (2026-2031)
4.1.3 Global Peptide Antibiotics Sales Market Share by Type (2020-2031)
4.2 Global Peptide Antibiotics Revenue by Type (2020-2031)
4.2.1 Global Peptide Antibiotics Revenue by Type (2020-2025)
4.2.2 Global Peptide Antibiotics Revenue by Type (2026-2031)
4.2.3 Global Peptide Antibiotics Revenue Market Share by Type (2020-2031)
4.3 Global Peptide Antibiotics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peptide Antibiotics Sales by Application (2020-2031)
5.1.1 Global Peptide Antibiotics Sales by Application (2020-2025)
5.1.2 Global Peptide Antibiotics Sales by Application (2026-2031)
5.1.3 Global Peptide Antibiotics Sales Market Share by Application (2020-2031)
5.2 Global Peptide Antibiotics Revenue by Application (2020-2031)
5.2.1 Global Peptide Antibiotics Revenue by Application (2020-2025)
5.2.2 Global Peptide Antibiotics Revenue by Application (2026-2031)
5.2.3 Global Peptide Antibiotics Revenue Market Share by Application (2020-2031)
5.3 Global Peptide Antibiotics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Peptide Antibiotics Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Peptide Antibiotics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Peptide Antibiotics Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly Peptide Antibiotics Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Theravance
6.5.1 Theravance Company Information
6.5.2 Theravance Description and Business Overview
6.5.3 Theravance Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Theravance Peptide Antibiotics Product Portfolio
6.5.5 Theravance Recent Developments/Updates
6.6 Vicuron Pharmaceuticals
6.6.1 Vicuron Pharmaceuticals Company Information
6.6.2 Vicuron Pharmaceuticals Description and Business Overview
6.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolio
6.6.5 Vicuron Pharmaceuticals Recent Developments/Updates
6.7 Savara Pharmaceuticals
6.7.1 Savara Pharmaceuticals Company Information
6.7.2 Savara Pharmaceuticals Description and Business Overview
6.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Savara Pharmaceuticals Peptide Antibiotics Product Portfolio
6.7.5 Savara Pharmaceuticals Recent Developments/Updates
6.8 AMP Therapeutics
6.8.1 AMP Therapeutics Company Information
6.8.2 AMP Therapeutics Description and Business Overview
6.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AMP Therapeutics Peptide Antibiotics Product Portfolio
6.8.5 AMP Therapeutics Recent Developments/Updates
6.9 Hospira
6.9.1 Hospira Company Information
6.9.2 Hospira Description and Business Overview
6.9.3 Hospira Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hospira Peptide Antibiotics Product Portfolio
6.9.5 Hospira Recent Developments/Updates
6.10 Kasten
6.10.1 Kasten Company Information
6.10.2 Kasten Description and Business Overview
6.10.3 Kasten Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kasten Peptide Antibiotics Product Portfolio
6.10.5 Kasten Recent Developments/Updates
6.11 Madam Therapeutics
6.11.1 Madam Therapeutics Company Information
6.11.2 Madam Therapeutics Description and Business Overview
6.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Madam Therapeutics Peptide Antibiotics Product Portfolio
6.11.5 Madam Therapeutics Recent Developments/Updates
6.12 Phosphagenics
6.12.1 Phosphagenics Company Information
6.12.2 Phosphagenics Description and Business Overview
6.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Phosphagenics Peptide Antibiotics Product Portfolio
6.12.5 Phosphagenics Recent Developments/Updates
6.13 Pacgen Life Science Corporation
6.13.1 Pacgen Life Science Corporation Company Information
6.13.2 Pacgen Life Science Corporation Description and Business Overview
6.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pacgen Life Science Corporation Peptide Antibiotics Product Portfolio
6.13.5 Pacgen Life Science Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Antibiotics Industry Chain Analysis
7.2 Peptide Antibiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Antibiotics Production Mode & Process Analysis
7.4 Peptide Antibiotics Sales and Marketing
7.4.1 Peptide Antibiotics Sales Channels
7.4.2 Peptide Antibiotics Distributors
7.5 Peptide Antibiotics Customer Analysis
8 Peptide Antibiotics Market Dynamics
8.1 Peptide Antibiotics Industry Trends
8.2 Peptide Antibiotics Market Drivers
8.3 Peptide Antibiotics Market Challenges
8.4 Peptide Antibiotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Peptide Antibiotics by Type
1.2.1 Global Peptide Antibiotics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ribosomal Synthesized Peptide Antibiotics
1.2.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Peptide Antibiotics by Application
1.3.1 Global Peptide Antibiotics Market Value by Application (2024 VS 2031)
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 Global Peptide Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Peptide Antibiotics Revenue 2020-2031
1.4.2 Global Peptide Antibiotics Sales 2020-2031
1.4.3 Global Peptide Antibiotics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peptide Antibiotics Market Competition by Manufacturers
2.1 Global Peptide Antibiotics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peptide Antibiotics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peptide Antibiotics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peptide Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide Antibiotics, Product Type & Application
2.7 Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
2.8 Global Peptide Antibiotics Market Competitive Situation and Trends
2.8.1 Global Peptide Antibiotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peptide Antibiotics Players Market Share by Revenue
2.8.3 Global Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peptide Antibiotics Market Scenario by Region
3.1 Global Peptide Antibiotics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peptide Antibiotics Sales by Region: 2020-2031
3.2.1 Global Peptide Antibiotics Sales by Region: 2020-2025
3.2.2 Global Peptide Antibiotics Sales by Region: 2026-2031
3.3 Global Peptide Antibiotics Revenue by Region: 2020-2031
3.3.1 Global Peptide Antibiotics Revenue by Region: 2020-2025
3.3.2 Global Peptide Antibiotics Revenue by Region: 2026-2031
3.4 North America Peptide Antibiotics Market Facts & Figures by Country
3.4.1 North America Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peptide Antibiotics Sales by Country (2020-2031)
3.4.3 North America Peptide Antibiotics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peptide Antibiotics Market Facts & Figures by Country
3.5.1 Europe Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peptide Antibiotics Sales by Country (2020-2031)
3.5.3 Europe Peptide Antibiotics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Peptide Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peptide Antibiotics Sales by Region (2020-2031)
3.6.3 Asia Pacific Peptide Antibiotics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peptide Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peptide Antibiotics Sales by Country (2020-2031)
3.7.3 Latin America Peptide Antibiotics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide Antibiotics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peptide Antibiotics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peptide Antibiotics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peptide Antibiotics Sales by Type (2020-2031)
4.1.1 Global Peptide Antibiotics Sales by Type (2020-2025)
4.1.2 Global Peptide Antibiotics Sales by Type (2026-2031)
4.1.3 Global Peptide Antibiotics Sales Market Share by Type (2020-2031)
4.2 Global Peptide Antibiotics Revenue by Type (2020-2031)
4.2.1 Global Peptide Antibiotics Revenue by Type (2020-2025)
4.2.2 Global Peptide Antibiotics Revenue by Type (2026-2031)
4.2.3 Global Peptide Antibiotics Revenue Market Share by Type (2020-2031)
4.3 Global Peptide Antibiotics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peptide Antibiotics Sales by Application (2020-2031)
5.1.1 Global Peptide Antibiotics Sales by Application (2020-2025)
5.1.2 Global Peptide Antibiotics Sales by Application (2026-2031)
5.1.3 Global Peptide Antibiotics Sales Market Share by Application (2020-2031)
5.2 Global Peptide Antibiotics Revenue by Application (2020-2031)
5.2.1 Global Peptide Antibiotics Revenue by Application (2020-2025)
5.2.2 Global Peptide Antibiotics Revenue by Application (2026-2031)
5.2.3 Global Peptide Antibiotics Revenue Market Share by Application (2020-2031)
5.3 Global Peptide Antibiotics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Peptide Antibiotics Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Peptide Antibiotics Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Peptide Antibiotics Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly Peptide Antibiotics Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Theravance
6.5.1 Theravance Company Information
6.5.2 Theravance Description and Business Overview
6.5.3 Theravance Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Theravance Peptide Antibiotics Product Portfolio
6.5.5 Theravance Recent Developments/Updates
6.6 Vicuron Pharmaceuticals
6.6.1 Vicuron Pharmaceuticals Company Information
6.6.2 Vicuron Pharmaceuticals Description and Business Overview
6.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolio
6.6.5 Vicuron Pharmaceuticals Recent Developments/Updates
6.7 Savara Pharmaceuticals
6.7.1 Savara Pharmaceuticals Company Information
6.7.2 Savara Pharmaceuticals Description and Business Overview
6.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Savara Pharmaceuticals Peptide Antibiotics Product Portfolio
6.7.5 Savara Pharmaceuticals Recent Developments/Updates
6.8 AMP Therapeutics
6.8.1 AMP Therapeutics Company Information
6.8.2 AMP Therapeutics Description and Business Overview
6.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AMP Therapeutics Peptide Antibiotics Product Portfolio
6.8.5 AMP Therapeutics Recent Developments/Updates
6.9 Hospira
6.9.1 Hospira Company Information
6.9.2 Hospira Description and Business Overview
6.9.3 Hospira Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hospira Peptide Antibiotics Product Portfolio
6.9.5 Hospira Recent Developments/Updates
6.10 Kasten
6.10.1 Kasten Company Information
6.10.2 Kasten Description and Business Overview
6.10.3 Kasten Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kasten Peptide Antibiotics Product Portfolio
6.10.5 Kasten Recent Developments/Updates
6.11 Madam Therapeutics
6.11.1 Madam Therapeutics Company Information
6.11.2 Madam Therapeutics Description and Business Overview
6.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Madam Therapeutics Peptide Antibiotics Product Portfolio
6.11.5 Madam Therapeutics Recent Developments/Updates
6.12 Phosphagenics
6.12.1 Phosphagenics Company Information
6.12.2 Phosphagenics Description and Business Overview
6.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Phosphagenics Peptide Antibiotics Product Portfolio
6.12.5 Phosphagenics Recent Developments/Updates
6.13 Pacgen Life Science Corporation
6.13.1 Pacgen Life Science Corporation Company Information
6.13.2 Pacgen Life Science Corporation Description and Business Overview
6.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pacgen Life Science Corporation Peptide Antibiotics Product Portfolio
6.13.5 Pacgen Life Science Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide Antibiotics Industry Chain Analysis
7.2 Peptide Antibiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide Antibiotics Production Mode & Process Analysis
7.4 Peptide Antibiotics Sales and Marketing
7.4.1 Peptide Antibiotics Sales Channels
7.4.2 Peptide Antibiotics Distributors
7.5 Peptide Antibiotics Customer Analysis
8 Peptide Antibiotics Market Dynamics
8.1 Peptide Antibiotics Industry Trends
8.2 Peptide Antibiotics Market Drivers
8.3 Peptide Antibiotics Market Challenges
8.4 Peptide Antibiotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Peptide Antibiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide Antibiotics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide Antibiotics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide Antibiotics Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Peptide Antibiotics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide Antibiotics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide Antibiotics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide Antibiotics Average Price (USD/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Antibiotics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Antibiotics, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Antibiotics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 18. Global Peptide Antibiotics Sales Market Share by Region (2020-2025)
Table 19. Global Peptide Antibiotics Sales by Region (2026-2031) & (MT)
Table 20. Global Peptide Antibiotics Sales Market Share by Region (2026-2031)
Table 21. Global Peptide Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide Antibiotics Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide Antibiotics Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 27. North America Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 28. North America Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 32. Europe Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 33. Europe Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide Antibiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Peptide Antibiotics Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Peptide Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 42. Latin America Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 43. Latin America Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide Antibiotics Sales (MT) by Type (2020-2025)
Table 51. Global Peptide Antibiotics Sales (MT) by Type (2026-2031)
Table 52. Global Peptide Antibiotics Sales Market Share by Type (2020-2025)
Table 53. Global Peptide Antibiotics Sales Market Share by Type (2026-2031)
Table 54. Global Peptide Antibiotics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide Antibiotics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide Antibiotics Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide Antibiotics Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide Antibiotics Price (USD/Kg) by Type (2020-2025)
Table 59. Global Peptide Antibiotics Price (USD/Kg) by Type (2026-2031)
Table 60. Global Peptide Antibiotics Sales (MT) by Application (2020-2025)
Table 61. Global Peptide Antibiotics Sales (MT) by Application (2026-2031)
Table 62. Global Peptide Antibiotics Sales Market Share by Application (2020-2025)
Table 63. Global Peptide Antibiotics Sales Market Share by Application (2026-2031)
Table 64. Global Peptide Antibiotics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide Antibiotics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide Antibiotics Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide Antibiotics Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide Antibiotics Price (USD/Kg) by Application (2020-2025)
Table 69. Global Peptide Antibiotics Price (USD/Kg) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. Pfizer Peptide Antibiotics Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Novartis Peptide Antibiotics Product
Table 79. Novartis Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Peptide Antibiotics Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Eli Lilly Peptide Antibiotics Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Theravance Company Information
Table 91. Theravance Description and Business Overview
Table 92. Theravance Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Theravance Peptide Antibiotics Product
Table 94. Theravance Recent Developments/Updates
Table 95. Vicuron Pharmaceuticals Company Information
Table 96. Vicuron Pharmaceuticals Description and Business Overview
Table 97. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Vicuron Pharmaceuticals Peptide Antibiotics Product
Table 99. Vicuron Pharmaceuticals Recent Developments/Updates
Table 100. Savara Pharmaceuticals Company Information
Table 101. Savara Pharmaceuticals Description and Business Overview
Table 102. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Savara Pharmaceuticals Peptide Antibiotics Product
Table 104. Savara Pharmaceuticals Recent Developments/Updates
Table 105. AMP Therapeutics Company Information
Table 106. AMP Therapeutics Description and Business Overview
Table 107. AMP Therapeutics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. AMP Therapeutics Peptide Antibiotics Product
Table 109. AMP Therapeutics Recent Developments/Updates
Table 110. Hospira Company Information
Table 111. Hospira Description and Business Overview
Table 112. Hospira Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Hospira Peptide Antibiotics Product
Table 114. Hospira Recent Developments/Updates
Table 115. Kasten Company Information
Table 116. Kasten Description and Business Overview
Table 117. Kasten Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Kasten Peptide Antibiotics Product
Table 119. Kasten Recent Developments/Updates
Table 120. Madam Therapeutics Company Information
Table 121. Madam Therapeutics Description and Business Overview
Table 122. Madam Therapeutics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Madam Therapeutics Peptide Antibiotics Product
Table 124. Madam Therapeutics Recent Developments/Updates
Table 125. Phosphagenics Company Information
Table 126. Phosphagenics Description and Business Overview
Table 127. Phosphagenics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Phosphagenics Peptide Antibiotics Product
Table 129. Phosphagenics Recent Developments/Updates
Table 130. Pacgen Life Science Corporation Company Information
Table 131. Pacgen Life Science Corporation Description and Business Overview
Table 132. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Pacgen Life Science Corporation Peptide Antibiotics Product
Table 134. Pacgen Life Science Corporation Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Peptide Antibiotics Distributors List
Table 138. Peptide Antibiotics Customers List
Table 139. Peptide Antibiotics Market Trends
Table 140. Peptide Antibiotics Market Drivers
Table 141. Peptide Antibiotics Market Challenges
Table 142. Peptide Antibiotics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide Antibiotics
Figure 2. Global Peptide Antibiotics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Antibiotics Market Share by Type: 2024 & 2031
Figure 4. Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure 5. Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Figure 6. Global Peptide Antibiotics Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide Antibiotics Market Share by Application: 2024 & 2031
Figure 8. Pharma & Healthcare
Figure 9. Food Industry
Figure 10. Commodities
Figure 11. Other
Figure 12. Global Peptide Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide Antibiotics Market Size (2020-2031) & (US$ Million)
Figure 14. Global Peptide Antibiotics Sales (2020-2031) & (MT)
Figure 15. Global Peptide Antibiotics Average Price (USD/Kg) & (2020-2031)
Figure 16. Peptide Antibiotics Report Years Considered
Figure 17. Peptide Antibiotics Sales Share by Manufacturers in 2024
Figure 18. Global Peptide Antibiotics Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Peptide Antibiotics Players: Market Share by Revenue in Peptide Antibiotics in 2024
Figure 20. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Peptide Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 23. North America Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 27. Europe Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 28. Germany Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Peptide Antibiotics Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Peptide Antibiotics Revenue Market Share by Region (2020-2031)
Figure 35. China Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Peptide Antibiotics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Peptide Antibiotics by Type (2020-2031)
Figure 57. Global Peptide Antibiotics Price (USD/Kg) by Type (2020-2031)
Figure 58. Global Sales Market Share of Peptide Antibiotics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Peptide Antibiotics by Application (2020-2031)
Figure 60. Global Peptide Antibiotics Price (USD/Kg) by Application (2020-2031)
Figure 61. Peptide Antibiotics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Peptide Antibiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Peptide Antibiotics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Peptide Antibiotics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Peptide Antibiotics Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Peptide Antibiotics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Peptide Antibiotics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Peptide Antibiotics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Peptide Antibiotics Average Price (USD/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Peptide Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Peptide Antibiotics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Peptide Antibiotics, Product Type & Application
Table 12. Global Key Manufacturers of Peptide Antibiotics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Antibiotics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Peptide Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 18. Global Peptide Antibiotics Sales Market Share by Region (2020-2025)
Table 19. Global Peptide Antibiotics Sales by Region (2026-2031) & (MT)
Table 20. Global Peptide Antibiotics Sales Market Share by Region (2026-2031)
Table 21. Global Peptide Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Peptide Antibiotics Revenue Market Share by Region (2020-2025)
Table 23. Global Peptide Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Peptide Antibiotics Revenue Market Share by Region (2026-2031)
Table 25. North America Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 27. North America Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 28. North America Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 32. Europe Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 33. Europe Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Peptide Antibiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Peptide Antibiotics Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Peptide Antibiotics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Peptide Antibiotics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 42. Latin America Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 43. Latin America Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Peptide Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Peptide Antibiotics Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Peptide Antibiotics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Peptide Antibiotics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Peptide Antibiotics Sales (MT) by Type (2020-2025)
Table 51. Global Peptide Antibiotics Sales (MT) by Type (2026-2031)
Table 52. Global Peptide Antibiotics Sales Market Share by Type (2020-2025)
Table 53. Global Peptide Antibiotics Sales Market Share by Type (2026-2031)
Table 54. Global Peptide Antibiotics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Peptide Antibiotics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Peptide Antibiotics Revenue Market Share by Type (2020-2025)
Table 57. Global Peptide Antibiotics Revenue Market Share by Type (2026-2031)
Table 58. Global Peptide Antibiotics Price (USD/Kg) by Type (2020-2025)
Table 59. Global Peptide Antibiotics Price (USD/Kg) by Type (2026-2031)
Table 60. Global Peptide Antibiotics Sales (MT) by Application (2020-2025)
Table 61. Global Peptide Antibiotics Sales (MT) by Application (2026-2031)
Table 62. Global Peptide Antibiotics Sales Market Share by Application (2020-2025)
Table 63. Global Peptide Antibiotics Sales Market Share by Application (2026-2031)
Table 64. Global Peptide Antibiotics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Peptide Antibiotics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Peptide Antibiotics Revenue Market Share by Application (2020-2025)
Table 67. Global Peptide Antibiotics Revenue Market Share by Application (2026-2031)
Table 68. Global Peptide Antibiotics Price (USD/Kg) by Application (2020-2025)
Table 69. Global Peptide Antibiotics Price (USD/Kg) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. Pfizer Peptide Antibiotics Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. Novartis Peptide Antibiotics Product
Table 79. Novartis Recent Developments/Updates
Table 80. GlaxoSmithKline Company Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Peptide Antibiotics Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. Eli Lilly Peptide Antibiotics Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Theravance Company Information
Table 91. Theravance Description and Business Overview
Table 92. Theravance Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Theravance Peptide Antibiotics Product
Table 94. Theravance Recent Developments/Updates
Table 95. Vicuron Pharmaceuticals Company Information
Table 96. Vicuron Pharmaceuticals Description and Business Overview
Table 97. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Vicuron Pharmaceuticals Peptide Antibiotics Product
Table 99. Vicuron Pharmaceuticals Recent Developments/Updates
Table 100. Savara Pharmaceuticals Company Information
Table 101. Savara Pharmaceuticals Description and Business Overview
Table 102. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Savara Pharmaceuticals Peptide Antibiotics Product
Table 104. Savara Pharmaceuticals Recent Developments/Updates
Table 105. AMP Therapeutics Company Information
Table 106. AMP Therapeutics Description and Business Overview
Table 107. AMP Therapeutics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. AMP Therapeutics Peptide Antibiotics Product
Table 109. AMP Therapeutics Recent Developments/Updates
Table 110. Hospira Company Information
Table 111. Hospira Description and Business Overview
Table 112. Hospira Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Hospira Peptide Antibiotics Product
Table 114. Hospira Recent Developments/Updates
Table 115. Kasten Company Information
Table 116. Kasten Description and Business Overview
Table 117. Kasten Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. Kasten Peptide Antibiotics Product
Table 119. Kasten Recent Developments/Updates
Table 120. Madam Therapeutics Company Information
Table 121. Madam Therapeutics Description and Business Overview
Table 122. Madam Therapeutics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. Madam Therapeutics Peptide Antibiotics Product
Table 124. Madam Therapeutics Recent Developments/Updates
Table 125. Phosphagenics Company Information
Table 126. Phosphagenics Description and Business Overview
Table 127. Phosphagenics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Phosphagenics Peptide Antibiotics Product
Table 129. Phosphagenics Recent Developments/Updates
Table 130. Pacgen Life Science Corporation Company Information
Table 131. Pacgen Life Science Corporation Description and Business Overview
Table 132. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Pacgen Life Science Corporation Peptide Antibiotics Product
Table 134. Pacgen Life Science Corporation Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Peptide Antibiotics Distributors List
Table 138. Peptide Antibiotics Customers List
Table 139. Peptide Antibiotics Market Trends
Table 140. Peptide Antibiotics Market Drivers
Table 141. Peptide Antibiotics Market Challenges
Table 142. Peptide Antibiotics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Peptide Antibiotics
Figure 2. Global Peptide Antibiotics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide Antibiotics Market Share by Type: 2024 & 2031
Figure 4. Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure 5. Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Figure 6. Global Peptide Antibiotics Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide Antibiotics Market Share by Application: 2024 & 2031
Figure 8. Pharma & Healthcare
Figure 9. Food Industry
Figure 10. Commodities
Figure 11. Other
Figure 12. Global Peptide Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide Antibiotics Market Size (2020-2031) & (US$ Million)
Figure 14. Global Peptide Antibiotics Sales (2020-2031) & (MT)
Figure 15. Global Peptide Antibiotics Average Price (USD/Kg) & (2020-2031)
Figure 16. Peptide Antibiotics Report Years Considered
Figure 17. Peptide Antibiotics Sales Share by Manufacturers in 2024
Figure 18. Global Peptide Antibiotics Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Peptide Antibiotics Players: Market Share by Revenue in Peptide Antibiotics in 2024
Figure 20. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Peptide Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 23. North America Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 27. Europe Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 28. Germany Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Peptide Antibiotics Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Peptide Antibiotics Revenue Market Share by Region (2020-2031)
Figure 35. China Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 46. Latin America Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Peptide Antibiotics Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Peptide Antibiotics Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Peptide Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Peptide Antibiotics by Type (2020-2031)
Figure 56. Global Revenue Market Share of Peptide Antibiotics by Type (2020-2031)
Figure 57. Global Peptide Antibiotics Price (USD/Kg) by Type (2020-2031)
Figure 58. Global Sales Market Share of Peptide Antibiotics by Application (2020-2031)
Figure 59. Global Revenue Market Share of Peptide Antibiotics by Application (2020-2031)
Figure 60. Global Peptide Antibiotics Price (USD/Kg) by Application (2020-2031)
Figure 61. Peptide Antibiotics Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232